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ABSTRACT The fusion peptides of HIV and inﬂuenza virus are crucial for viral entry into a host cell. We report the membrane-
perturbing and structural properties of fusion peptides from the HA fusion protein of inﬂuenza virus and the gp41 fusion protein
of HIV. Our goals were to determine: 1), how fusion peptides alter structure within the bilayers of fusogenic and nonfusogenic
lipid vesicles and 2), how fusion peptide structure is related to the ability to promote fusion. Fluorescent probes revealed that
neither peptide had a signiﬁcant effect on bilayer packing at the water-membrane interface, but both increased acyl chain order
in both fusogenic and nonfusogenic vesicles. Both also reduced free volume within the bilayer as indicated by partitioning of
a lipophilic ﬂuorophore into membranes. These membrane ordering effects were smaller for the gp41 peptide than for the HA
peptide at low peptide/lipid ratio, suggesting that the two peptides assume different structures on membranes. The inﬂuenza
peptide was predominantly helical, and the gp41 peptide was predominantly antiparallel b-sheet when membrane bound,
however, the depths of penetration of Trps of both peptides into neutral membranes were similar and independent of membrane
composition. We previously demonstrated: 1), the abilities of both peptides to promote fusion but not initial intermediate
formation during PEG-mediated fusion and 2), the ability of hexadecane to compete with this effect of the fusion peptides.
Taken together, our current and past results suggest a hypothesis for a common mechanism by which these two viral fusion
peptides promote fusion.
INTRODUCTION
Membrane fusion is fundamental to the life of eukaryotic
cells. Cellular trafﬁcking and compartmentalization, sexual
reproduction, cell division, and protein sorting are dependent
on this basic event. Membrane fusion mediated by the
envelope glycoproteins of inﬂuenza virus (hemagglutinin,
HA0) (1–3) and of the human immunodeﬁciency virus (HIV-1;
gp160) (4,5) has been extensively studied. Both envelope
proteins consist of two associated parts: one binds a receptor
(HA1/gp120) whereas the other promotes membrane fusion
(HA2/gp41). Glycoprotein gp120 binds to the cell surface
receptor CD4 (6) and chemokine receptors (7) and undergoes
conformational changes that trigger binding to its companion
peptide, gp41 (4,8). Similarly, the HA1 component of HA0
contains sialic acid binding sites that bind to the cell surface
receptor, GM1. Both gp41 and HA2 form trimers and
undergo a conformational change (HA2 at low pH and gp41
through its association with CD4-bound gp120) to a state
that is able to catalyze fusion of the viral envelope with a cell
membrane (surface membrane for gp41 and endosome mem-
brane for HA) (9–12). These conformational changes in HA
and gp41 expose N-terminal amphipathic, glycine-rich re-
gions of 20–25 amino acids (11,13). Mutations in these
regions can block fusion-mediated viral infection, so they
are termed ‘‘fusion peptides’’ (14).
The fusion peptide regions of viral fusion proteins
associate with target membranes (15,16) and, based on
studies of the effect of synthetic fusion peptides, are widely
viewed as destabilizing membranes to promote fusion (17–
22). This view has been challenged by reports that the high
peptide concentrations used in most studies compromise
bilayer integrity rather than induce fusion (23,24). However,
both peptides, when present at low surface concentrations,
do promote fusion when poly(ethylene glycol) (PEG) or
Ca21 bring membranes into close contact (23–25). Under
the condition of low surface concentration, these peptides
promote fusion pore formation to a greater extent than they
promote formation of an initial ‘‘hemifusion intermediate’’
(contacting bilayer leaﬂets joined but no stable pore formed)
(23,24).
The mechanism by which N-terminal fusion peptides
promote fusion is not clear, although the literature offers
several suggestions. Several articles have suggested that
some peptide secondary structures are fusogenic and some
are not (25–28). Others have suggested that fusion peptides
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perturb the bilayer surface (i.e., increase surface tension
and destabilize the bilayer) (29,30). Our observations led to
the proposal that fusion peptides promote pore formation
by ﬁlling space within intermediate nonbilayer structures
to promote pore formation (23,24). The current study was
undertaken to ask whether the structures of the peptides on
a bilayer and the effects of peptides on different regions of
the bilayer might be consistent with one or more of these
interpretations. Because we found that these two fusion
peptides promoted fusion only of highly curved membranes
(23,24), we also asked here whether the peptides might
behave differently on bilayers of different compositions and
curvature.
To answer these questions, we have examined complexes
formed by fusion peptides and lipid vesicles using intrinsic
ﬂuorescence, ﬂuorescent probes of membrane order, circular
dichroism spectroscopy (CD), and Fourier transform infrared
(FTIR) spectroscopy. Our measurements reveal no clear rela-
tionship between peptide structure and the ability to promote
pore formation. However, both peptides increased chain
packing or order within the hydrophobic core of the bilayer
but had little change in the packing or structure of the
interfacial region of the bilayer. These results argue against
a role for fusion peptides in disrupting the surface packing of
the unfused state but are consistent with our previous sug-
gestion that fusion peptides occupy hydrophobic mismatch
(HMM) regions of nonbilayer structures to promote fusion
(23,24). A structural hypothesis is presented that proposes
how two peptides with different secondary structures might
have this common effect.
MATERIALS AND METHODS
Chloroform stock solutions of 1,2-dioleoyl-3-sn-phosphati-
dylcholine (DOPC), 1-palmitoyl-2-oleoyl-3-sn-phosphati-
dylcholine (POPC), 1,2-dioleoyl-3-sn-phosphatidylethanolamine
(DOPE), 1,2-dioleoyl-3-sn-phosphatidylserine (DOPS), bovine
brain sphingomyelin (SM), 1-palmitoyl-2-stearoyl (6-7 dibromo)-
sn-glycero-3-phosphocholine (6-7 Bromo-PC), 1-palmitoyl-2-
stearoyl (11-12 dibromo)-sn-glycero-3-phosphocholine (11-12
Bromo-PC), 1-palmitoyl-2-N-(4-nitrobenzo-2-oxa-1,3-diazole)
aminohexanoyl phosphatidylcholine (C6-NBD-PC) were pur-
chased from Avanti Polar Lipids (Birmingham, AL) and used
without further puriﬁcation. The concentration of all the stock
lipids was determined by phosphate assay (31). Cholesterol (CH)
was purchased fromAvanti Polar Lipids and was further puriﬁed
by published procedures (32). 1,6-diphenyl-1,3,5-hexatriene
(DPH) and 1-(4-trimethyammonium)-6-phenyl-1,3,5-hexatriene
(TMA-DPH) were purchased from Molecular Probes (Eugene,
OR). N-[tris(hydroxymethyl) methyl]2-2-aminoethane sulfonic
acid (TES) were purchased from Sigma Chemical (St. Louis,
MO). Deuterium oxide (99.8% deuterated) was purchased from
AldrichChemical (Milwaukee,WI).Allother reagentswereof the
highest purity grade available.
METHODS
Vesicle preparation
Vesicles were prepared from DOPC, POPC, or from a mixture of DOPC/
DOPE/SM/CH in the molar ratio 35:30:15:20. Lipids at appropriate molar
ratios in chloroform were freeze dried under high vacuum overnight.
Small unilamellar vesicles (SUVs) were prepared as reported previously (33).
The dried lipid powders were suspended in an appropriate buffer for 1 h
above the main phase transition. Large unilamellar vesicles (LUVs) were
prepared by the extrusion method (34), using 10 passes through a 0.1 mm
polycarbonate ﬁlter (Nucleo Pore, Pleasantor, CA) at room temperature under
a pressure of 100 psi of N2. Details of this method are described in an earlier
publication (35). The buffer contained 100 mM NaCl, 1 mM EDTA, and
1 mMCaCl2 at either pH 7.5 (adjusted with 10 mMTES), or pH 5.5 (adjusted
with 10 mM MES). Measurements were carried out using 0.2 mM lipid.
Preparation of gp41 and HA peptides
The X-31 HA (native) and the gp41 fusion peptides (native and mutant) were
chemically synthesized and puriﬁed by the peptide synthesis laboratory at
the University of North Carolina, Chapel Hill (David Klapper, director). The
sequences of the peptides areGLFGAIAGFIENGWEGMIDG (X-31 HA,
native), AVGIGALFLGFLGAAGSTMGARS (gp41, native) and AVGI-
GALWLGFLGAAGSTMGARS (gp41, mutant). The peptides were
synthesized by the standard solid phase method using fMOC chemistry.
Detailed descriptions of the synthesis and puriﬁcation of these peptides are
given in previous publications (23,24). Stock peptide solutions were prep-
ared in DMSO solvent, and small aliquots of these solutions were added to
vesicle suspensions. DMSO was always ,1% of the buffer volume, and
control experiments showed that this amount of DMSO had no effect on the
surface properties of the bilayers.
DPH and TMA-DPH ﬂuorescence anisotropy
Incorporation of DPH and TMA-DPH into membranes was accomplished by
adding a small volume (0.04–0.08% of vesicle sample volumes) of stock
solutions of either DPH or TMA-DPH in methanol to vesicle suspensions to
achieve a ﬁnal lipid/probe ratio of 200:1. The mixtures were vortexed
thoroughly and incubated until the ﬂuorescence intensity did not increase
further with time (;30 min). Aliquots of peptide were then added to the
vesicle suspensions, and ﬂuorescence anisotropy was recorded after10 min
incubation. All ﬂuorescence measurements were performed using an SLM
48000 spectroﬂuorometer (SLM Aminco, Urbana, IL). The excitation
wavelength was 360 nm, with excitation slits of 4 and 4 nm and 450 cutoff
ﬁlters in the T-format emission paths.
C6-NBD-PC and TMA-DPH lifetime measurements
C6-NBD-PC and TMA-DPH, both in methanol, were added to vesicle
samples to give 200:1 lipid/probe ratios and incubated with stirring until
constant ﬂuorescence intensity was observed. For both probes, increasing
quantities of peptide were titrated into a solution containing 0.2 mM DOPC/
DOPE/SM/CH and DOPC vesicles, and phase shift and modulation ratios
were collected from continuously stirred samples using the SLM 48000
MHF spectroﬂuorometer equipped with a Coherent Inova 90 argon-ion
laser. Details of instrument setup, data acquisition, and analysis are
described in an earlier publication (36).
Depth of tryptophan residue of fusion peptides
in membranes
We have measured depth of penetration of the single peptide tryptophan
residue inside the lipid bilayers using the parallax method (37). Lipids
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labeled with bromine at carbons 6-7 and 11-12 in the acyl chain were used
as tryptophan quenchers (20 mol% brominated PCs in place of DOPC).
Aliquots of peptide solution were added to vesicle suspensions to achieve
a ﬁnal peptide/lipid ratio of 1:400 and incubated for 10 min before recording
tryptophan ﬂuorescence intensity. The signal from an identical sample
without peptide was subtracted from the data to reveal the Br quenching.
Depth of tryptophan was calculated according to published methods (37):
ZcF ¼ Lc11 f½ð1=pCÞ lnðF1=F2Þ  L221=2L21g; (1)
where ZcF is the depth of ﬂuorophore from the center of the bilayer, Lc1 is the
distance of the center of the bilayer from the shallow quencher 1, L21 is the
difference in depth between the two quenchers, and C is the two-dimensional
quencher concentration in the plane of the membrane in units of molecules
per unit area f(mol fraction of quencher lipid in total lipid)/(area of a PC
molecule)g. F1 and F2 are the measured normalized ﬂuorescence intensities
from samples containing the 6-7 dibromo and 11-12 dibromo quenchers,
respectively. The area of a PC molecule was taken as 70 A˚2 (38), and the
average bromine distances from the center of the bilayer were taken to be
10.8 and 6.3 A˚ for the 6-7 Br-PC and 11-12 Br-PC, respectively (39). Errors
in the depth of penetration from repeats with a single vesicle preparation
were 1–2% for HA peptide and 5–10% for gp41 peptide. The parallex
method is valid when all peptides are bound to the membrane, which they
should be under our conditions of excess lipid.
CD spectroscopy
Circular dichroism spectra were measured using an Applied Photophysics
model PiStar-180 spectropolarimeter (Surrey, UK) located in the UNC
Macromolecular Interactions Facility. Data were collected using 0.5-mm
pathlength cells at wavelengths from 250 to 200 nm at intervals of 0.2 nm.
Estimates of peptide secondary structure under different conditions were
made using published procedures (40). The peptide concentration was
40 mM, and the lipid concentration was 2 mM. Small aliquots of peptide
solution in DMSO were dried in thin ﬁlms on the surface of 3.5-ml brown
vials. The ﬁlms were frozen using dry ice, and dried under high vacuum
overnight. Preformed SUVs were added to the vials and vortexed for 30 min
to transfer peptide to the membranes.
Infrared spectroscopy
Polarized attenuated total internal reﬂection Fourier-transform infrared
(PATIR-FTIR) spectroscopy was performed using a FTS-60A spectrometer
(BioRad Digilab, Waltham MA) equipped with a liquid-nitrogen cooled
MCT detector coupled via a germanium internal reﬂection element to a lipid
ﬁlm balance as previously described (41). Monolayers were prepared by
applying phospholipids dissolved in hexane/methanol (9:1) to the buffer
surface in a Langmuir trough. The lipid spread at the air-water interface was
compressed to a surface pressure of 20 mN/m, and applied onto the internal
reﬂection element by placing an octadecyltrichlorosilane-treated germanium
internal reﬂection crystal ﬂat onto the monolayer (42,43).
After recording a baseline single-beam spectrum, aliquots of the peptide
(;10 mg) dissolved in deuterated DMSO were added to the continuously
stirred buffer subphase to a ﬁnal concentration of ;0.8 mM. Minor con-
tributions to the amide I spectrum arising from SM are included in the
baseline spectrum, and therefore do not contribute to the ﬁnal amide I
spectrum of the peptide. The DMSO concentration in the buffer subphase
was always ,0.3 wt%. Polarized infrared absorption spectra were recorded
by directing light from the Bio-Rad FTIR spectrometer through a polarizer
oriented either parallel or perpendicular to the plane deﬁned by the incident
beam of light (incidence angle ¼ 45) and the perpendicular axis of the
germanium crystal. After a series of internal reﬂections, the beam was directed
to an external detector (42). The depth of evanescent ﬁeld penetration into the
buffer subphase at the site of each internal reﬂection is ;0.5 mM, so that the
contribution of peptide in bulk solution to the spectra is negligible, and
virtually all the signal arises from membrane-bound peptide. All spectra were
collected in the rapid scan mode as 1024 coadded interferograms, with
a resolution of 2 cm1, scanning speed of 20MHz, triangular apodization, and
one level of zero ﬁlling. All experiments were performed at 27C. A single
horizontal baseline correction was applied to each spectrum, but no
smoothing, deconvolution, vapor subtraction, or other aesthetic processing.
Dichroic ratios, Rz ¼
R
Ak=
R
A?; were evaluated using linked analysis
(43) and integrated areas of the amide I absorption bands,
R
A; arising from
the backbone peptide groups. For an angle u between the absorption moment
and the surface normal, Rz ¼ 2:0 indicates either isotropic disorder, uniform
orientation at u ¼ 54:7 (the magic angle), or any distribution of orientations
for which Æcos2 uæ ¼ 1=3: Accordingly, Rz. 2:0 indicates that absorption
moments have preferential orientation more perpendicular to the plane of the
membrane than the magic angle, whereas Rz, 2:0 indicates preferential
orientation more parallel to the membrane than the magic angle. The range
of possible values for the dichroic ratio has a physical minimum at RZ ¼
0.88, corresponding to an orientation that is perfectly parallel to the
membrane (44). The fractional contributions of different band components
to the overall amide I band were calculated for the conditions of internal
reﬂection and polarized light as previously described (45).
RESULTS
Effect of peptide on bilayer properties
Effects of peptides on outer leaﬂet membrane packing
The effect of fusion peptides on membrane surface properties
was examined using a ﬂuorescent probe, C6-NBD-PC, which
is reported to partition between the upper region of the
bilayer and micelles (37). Because of this partitioning, the
ﬂuorescence lifetime of this probe reﬂects the lifetimes in
both membrane and micelle environments, with the average
lifetime reﬂecting the partition coefﬁcient between these two
phases (36), making C6-NBD-PC a sensitive function of
membrane surface free energy (i.e., surface tension) and lipid
packing within membrane outer leaﬂets (46). Measured
phase shift and modulation ratios of frequency-modulated
C6-NBD-PC ﬂuorescence at different lipid/peptide ratios in
vesicles composed of DOPC or DOPC/DOPE/SM/CH were
well described by three lifetime components. The smallest of
these components was independent of peptide/lipid ratio and
was thus taken as the probe lifetime in a micelle, whereas the
other two were taken to reﬂect C6-NBD-PC partitioned into
the membrane. Fig. 1 shows the peptide-induced shift in the
ﬂuorescence lifetime of membrane-associated C6-NBD-PC
(left panels), as well as the mol fraction of C6-NBD-PC in the
membranes as a function of the ratio of added-peptide/total-
lipid concentration (right panels). The average C6-NBD-PC
lifetime in DOPC SUVs (panel A), DOPC/DOPE/SM/CH
SUVs (panel B), and DOPC/DOPE/SM/CH LUVs (panel C)
increased with increasing peptide concentrations for both
HA (triangles) and gp41 (circles) fusion peptides. As ex-
pected from reports that HA peptide binds poorly to
membranes at neutral pH (18,47), our data indicate that the
HA peptide had no effect on C6-NBD-PC lifetime at pH 7.5
(panel A, open triangles). The effect of the gp41 peptide, on
the other hand, was independent of pH (Fig. 1 A, solid
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circles, pH 7.5, and open circles, pH 5.5), consistent with
reports that the gp41 peptide binds to membranes at both
neutral and acidic pH (48). For these reasons, we performed
most of our experiments with HA peptide at pH 5.5 and with
gp41 peptide at pH 7.5. For all three lipid systems, the effect
of the HA fusion peptide on C6-NBD-PC lifetime was
greater than for gp41 peptide, although the difference was
minimal for fusogenic DOPC/DOPE/SM/CH SUVs.
The inﬂuence of both peptides on C6-NBD-PC lifetime
reached a saturating level at high peptide concentration, but
had not saturated by a peptide/lipid ratio of roughly 1/30
for DOPC/DOPE/SM/CH LUVs or DOPC SUVs. As a con-
trol, we monitored binding of both peptides to the different
vesicles used in this study as described previously (23,24).
The resulting binding parameters are collected in Table 1.
The fraction of membrane surface sites occupied (fS) on
DOPC SUVs was calculated (49) from these binding param-
eters. For reference, we give values at low surface occu-
pancy (P/L ¼ 1/2000 fS ¼ 0.06 for HA and 0.05 for gp41
peptides) and high surface occupancy (P/L ¼ 1/250 fS ¼
0.51 for HA and 0.39 for gp41 peptides). At low P/L, both
peptides were well below surface saturation. Under these
conditions, nearly all peptide was bound. At high P/L,
surface occupancy was still fairly low, but surface crowding
cannot be ignored at high peptide concentration.
These observations suggest that peptide binding caused
either: 1), C6-NBD-PC to partition deeper into the mem-
brane outer leaﬂet, 2), water not to penetrate as deeply into
the outer leaﬂet, or 3), inhibited motions and increased packing
order in the neighborhood of the probe. We addressed all three
possibilities with additional experiments reported below.
For all three lipid systems, increasing peptide/lipid ratio
decreased the mol fraction of C6-NBD-PC partitioned into
the membranes, although the effects were qualitatively quite
different for curved and uncurved vesicles (compare panels
D and E of Fig. 1 to panel F). The two peptides inhibited C6-
NBD-PC partitioning into uncurved vesicles equally, but had
very different effects for curved vesicles (panels D and E).
Even a small amount of HA peptide signiﬁcantly inhibited
C6-NBD-PC partitioning from micelles into all three mem-
brane systems. However, binding of gp41 peptide to SUVs
seemed to occur with no effect on C6-NBD-PC partitioning
into these membranes up to a P/L ratio of 1:50, whereupon
partitioning decreased dramatically as it did for HA peptide.
These results suggest that both fusion peptides reduced free
volume in the membrane outer leaﬂet (i.e., increased lateral
packing pressure), although the gp41 peptide had to reach
a critical surface concentration on highly curved membranes
before this effect was observed. Because lifetime data in the
left panels indicate that the gp41 peptide binds to DOPC and
DOPC/DOPE/SM/CH SUVs, it may be that it assumes
a different structure on these membranes at low and high
surface concentrations. Interestingly, HA peptide (23) is
more active in destabilizing membrane vesicles than is the
gp41 peptide (24) at low peptide concentrations in the
absence of PEG. Thus, the abilities of these two peptides to
destabilize vesicles correlate with their abilities to increase
lateral pressure in the vesicle outer leaﬂet. However, the
FIGURE 1 Effects of fusion peptides on the surface
properties of fusogenic and nonfusogenic vesicles. The
ﬂuorescence lifetime of C6NBD-PC in the presence of
peptide relative to the lifetime in the absence of peptide
(Delta Lifetime) is presented as a function of gp41
(circles) and HA fusion (triangles) peptide/lipid ratios in
panels A, B, andC. The mol fractions (Xmem) of C6-NBD-
PC partitioned into DOPC SUVs (nonfusogenic), DOPC/
DOPE/SM/CH SUVs (fusogenic), and LUVs (nonfuso-
genic) are shown in panels D, E, and F. Open and solid
symbols show data obtained at pH 7.5 and 5.5, re-
spectively, and 23C.
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gp41 peptide at low peptide surface concentrations still
enhanced the rate of PEG-mediated DOPC/DOPE/SM/CH
SUV fusion (24), meaning that the gp41 structure at low
surface occupancy can promote fusion, whereas at high
surface occupancy it promotes rupture.
Effects of peptides on acyl chain packing
DPH locates in the hydrocarbon region of phospholipid bi-
layers and its ﬂuorescence anisotropy has long been used to
monitor chain-packing order in that region (50). Fig. 2 shows
the change of DPH ﬂuorescence anisotropy as a function of
HA (left panels) and gp41 (right panels) peptide/lipid ratio in
highly curved DOPC SUVs (nonfusogenic), DOPC/DOPE/
SM/CH SUVs (fusogenic), and uncurved DOPC/DOPE/SM/
CH LUVs (nonfusogenic). As we saw for lateral packing
pressure as detected by C6-NBD-PC partitioning, the gp41
peptide had little effect on DPH anisotropy at low surface
occupancies of peptide but did cause an increase in chain
packing order above a critical peptide/lipid ratio of ;1:67.
The HA peptide also caused an increase in acyl chain
packing as reported by DPH, but it did so at all peptide
surface occupancies. The results show that both peptides
increase packing in the acyl chain region, but, along with the
effects on surface packing recorded in Fig. 1, suggest that the
HA and gp41 peptides have different effects on membranes
at low surface occupancies. These results further support the
conclusion that the gp41 peptide has a different conforma-
tion at low (,1:67) and high surface concentrations.
Effect of peptides at the interface
TMA-DPH locates close to the membrane interface and
senses membrane structure in this region (51). The
ﬂuorescence anisotropy of TMA-DPH was thus used as
a measure of the chain packing in the upper reaches of the
bilayer outer leaﬂet. In Fig. 3, we present the ﬂuorescence
emission anisotropy of TMA-DPH in DOPC/DOPE/SM/CH
SUVs and LUVs and in DOPC SUVs as a function of HA
(triangles) and gp41 (circles) fusion peptide/lipid ratio.
TMA-DPH anisotropy increased somewhat with peptide
concentration in all cases. Although TMA-DPH ﬂuorescence
anisotropy was different for different membranes, the results
TABLE 1 Binding parameters for the association of fusion peptides with vesicle membranes
Peptides Parameters DOPC SUV DOPC LUV DOPC/DOPE/SM/CH SUV DOPC/DOPE/SM/CH LUV
HA Kd (mM) 0.96 6 0.6* 2.86 6 1.2* 2.94 6 0.9 4.0 6 2.6
Stoichiometry 13 6 2* 6 6 1* 22 6 2 16 6 3
gp41 Kd (mM) 3.4 6 1.3* 0.65 6 0.4 3.3 6 1.2 0.55 6 0.3
Stoichiometry 10 6 1* 10 6 1 7 6 0.3 9 6 0.5
*Values were taken from our previous publications (23,24). Details of experimental conditions, data analysis, and ﬁttings are described in earlier publications
(23,24,49).
FIGURE 2 Effect of fusion peptides on acyl chain packing. DPH
ﬂuorescence emission anisotropy in DOPC SUVs, DOPC/DOPE/SM/CH
(35:30:15:20) SUVs and DOPC/DOPE/SM/CH LUVs as a function of HA
(left panels) and gp41 (right panels) peptide/lipid ratio. The experiment was
done at 23C.
FIGURE 3 Effect of fusion peptides on the interfacial region of vesicle
membranes. The TMA-DPH ﬂuorescence emission anisotropy in DOPC/
DOPE/SM/CH (35:30:15:20) SUVs, LUVs, and DOPC SUVs is shown as
a function of HA (:) and gp41 (d) peptide/lipid ratio. All values represent
the average of three measurements with representative error bars shown.
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show that the packing in the interfacial region of all mem-
brane bilayers increased similarly with addition of both fusion
peptides (3–4% over a range of 0–1:25 peptide/lipid). This
increase in packing order was much smaller than the increase
in packing induced in the lower regions of the bilayer (Fig. 2;
21 and 10% for HA and gp41 peptides, respectively). These
results suggest that both peptides increased packing order in
the acyl chain region more than at the interface. We note that
a critical gp41 surface concentration was not needed to see the
effect on interfacial packing.
Effects of fusion peptides on bilayer water penetration
Water penetration into the interface region causes a drop in
TMA-DPH ﬂuorescence lifetime due to an exchangeable
hydrogen atom that should be located in the interface region
of the bilayer (51). The drop in lifetime is reversed by re-
placement of H2O with D2O (36). We determined the two
lifetime components required to describe the excited state
behavior of TMA-DPH in DOPC/DOPE/SM/CH SUVs at
various lipid/peptide ratios. To judge water penetration, we
calculated average lifetimes measured in D2O (t
D
Av2) and in
H2O (t
H
Av2) (36). The closer the tDAv2:tHAv2 ratio is to 1, the
less water penetrates into the interface region of the mem-
brane outer leaﬂet (51). Our results (ﬁgure shown as a sup-
plement) clearly showed that neither peptide affected water
penetration into the outer leaﬂet interface region of either
fusogenic (DOPC/DOPE/SM/CH) or nonfusogenic (DOPC)
SUVs, even at high peptide concentrations.
Peptide structure on the membrane
Depth of peptide penetration
The fusion peptides we have studied both have a single Trp
residue. We have used these residues as reporter groups to
judge the location of the peptides in the bilayer. The loca-
tions of these Trp residues were gauged by quenching of Trp
indole ﬂuorescence intensity based on the parallax method
(37). We used two dibromo lipids (6-7 and 11-12 Br-PC) as
quenchers. Trp ﬂuorescence was quenched (quenching re-
sults are not shown here, but are given in a supplement) more
by the 6-7 Br-PC than by the 11-12 Br-PC, suggesting that
the indole moiety was closer to the C6-C7 carbons in the lipid
acyl chain than to the C11-C12 carbons. Equation 1 in
Methods was used to estimate the location of indole moieties
in HA and gp41 peptides in the bilayers of membranes of
different compositions, with the distances of indoles from the
center of the bilayer reported in Table 2. These results indicate
that both peptides penetrate into the acyl chain region of lipid
bilayers. The quenching efﬁciency was less for the gp41 than
for the HA peptide and consequently the error of depth
estimation was greater for the gp41 peptide, even though we
obtained reproducible results with both peptides. Our results
(8.8–9.3 A˚ from the bilayer center) for HA peptide are
reasonably consistent with previous estimates (52,53), but dif-
fer slightly (just beyond the limits of precision) between mem-
branes of different inherent fusogenicity and curvature stress.
The distance of gp41 peptide Trp indole from the bilayer
center was roughly the same for the more fusogenic and less
fusogenic lipid compositions, at least within the precision
of these measurements. For both peptides, the apparent Trp
location was independent of bilayer curvature. Penetration of
gp41 peptide into the bilayer was independent of peptide
concentration. Penetration of gp41 was unchanged even at
peptide/lipid ratios (1:50) above the threshold of aggrega-
tion/rupture (;1:250 when PEG and peptide are both pre-
sent). This result demonstrates that high leakage or rupture
of vesicle in the presence of high peptide concentrations is
not simply due to greater penetration of peptide into the acyl
chain region.
Secondary structure/orientation of fusion
peptides on vesicles
Numerous CD experiments have established that the HA
fusion peptide adopts a largely a-helical structure when it
associates with membranes (18), and we have therefore not
pursued further CD studies of this peptide. We did, however,
examine this peptide by PATIR-FTIR, because previous
FTIR studies of dried HA-peptide-lipid suspensions suggest
that the peptide helix orients at an intermediate angle to the
bilayer normal (45–70) (54). In our hands, the HA peptide
did not adsorb well to monolayer membranes of either type at
pD 7.5, consistent with results obtained using lipid vesicles
(Fig. 1 A). Due to weak signals and inconsistent results,
spectra collected under these conditions were not quantita-
tively analyzed. HA peptide at pD 5.5 adsorbed well onto
POPC monolayers, exhibiting a single major broad amide I
component centered at 1649 cm1 and a minor component at
1677 cm1 (Fig. 4 A), characteristic of a-helix. Compared to
TABLE 2 Distance of indole group of Trp residue of HA and
gp41 fusion peptide from the center of the bilayer
of membrane vesicles
Peptide L/P ratio Vesicles
Distance from
bilayer center (A˚)
gp41 400:1 DOPC/DOPE/SM/CH, SUV 8.67
400:1 DOPC/DOPE/SM/CH, LUV 8.60
400:1 DOPC, SUV 8.65
50:1 DOPC, SUV 8.60
50:1 DOPC/DOPE/SM/CH, SUV 8.55
HA 400:1 DOPC/DOPE/SM/CH, SUV 8.88
400:1 DOPC/DOPE/SM/CH, LUV 8.97
400:1 DOPC, SUV 9.30
To achieve a 50:1 lipid/peptide ratio in some experiments with gp41
peptide, we have added wild-type (no Trp) peptide along with the mutant
peptide. This maintained a low surface concentration of Trp-mutant peptide
(L/P of 400:1) that allowed us to measure Trp depth in the membrane
without interference from high lipid to Trp containing peptide ratio but over
all high peptide concentration.
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POPC monolayers, spectra collected on DOPC/DOPE/SM/
CH monolayers exhibit an additional distinct component
at 1625 cm1 (Fig. 4 A), suggesting a small and ill-deﬁned
change in secondary structure (perhaps some b or more
complex structure). Our PATIR-FTIR results agree with
previously published CD (17–19,47,55–57) and FTIR (58–
60) studies of the HA fusion peptide in showing an a-helix
conformation when this peptide binds to liposome mem-
branes at low pH. However, our studies differ from previous
studies in that they were performed on well-oriented lipid
monolayers, making them suitable for quantitative analysis
of peptide orientation (43). Assuming that the peptide is
predominantly helical under these conditions, this analysis
yields dichroic ratios ranging from 1.7 to 1.9, indicating
either that the peptide exhibits only a modest amount of ori-
entational order or is oriented roughly at the magic angle with
respect to the bilayer plane.
The structure of gp41 peptide on neutral membranes is
less extensively characterized in the literature, and thus the
secondary structure of the HIV gp41 fusion peptide bound to
vesicles and monolayers was examined by both CD and
PATIR-FTIR spectroscopy. CD spectra of gp41 indicate that
it had negligible helical content on fusogenic DOPC/DOPE/
SM/CH SUVs and nonfusogenic DOPC vesicles (ﬁgure
shown as a supplement). Similar results were obtained with
DOPC vesicles containing 5 and 10 mol% DOPS. Apparent
helicity increased to ;20% in vesicles containing 50 mol%
DOPS (ﬁgure shown as a supplement), consistent with most
earlier studies showing that the gp41 peptide forms an
a-helix on charged membranes (22,25,61–63).
PATIR-FTIR spectra of gp41 fusion peptide exhibited
a widely split amide I band on POPC monolayers at pD 5.5
(data not shown) and at pD 7.5 (Fig. 4 B). The band com-
ponents at 1625 and 1688 cm1 that dominated the amide I
spectrum in POPC monolayers, are present but less
prominent in DOPC/DOPE/SM/CH monolayers. This
widely split amide I band is characteristic of antiparallel
b-sheet secondary structure (64,65). Quantitative analysis
indicates that gp41 was highly ordered under all conditions,
with dichroic ratios between 1.2 and 1.4 for its 1625 cm1
component (Table 3). This component is aligned parallel to
the hydrogen bonds in an antiparallel b-sheet, so these
dichroism results indicate that hydrogen bonds in the sheet
are parallel to the membrane surface. If we view the b-sheet
as a thin rectangle with one minor axis parallel to the
H-bonds and a long axis being the run of the sheet, the
H-bond axis is parallel to the plane of the membrane but the
long axis may be parallel or at an angle to the membrane nor-
mal. Other components in the spectra reveal little order, and
do not support speciﬁc interpretations.
DISCUSSION
Effects of fusion peptides on bilayer structure
The HA peptide had a somewhat greater effect on bilayer
structure than gp41 peptide. Consistent with this, the gp41
peptide had to reach a critical surface concentration (P/L ;
1:60) to have the same effects on outer leaﬂet free volume
(Fig. 1) and interior acyl chain order (Fig. 2). This implies that
the HA peptide penetrates the outer leaﬂet different from the
gp41 peptide. Nonetheless, both peptides increased packing in
the interface region of the outer leaﬂet to some extent (Fig. 3)
but to a much smaller extent than they increased interior
packing (Fig. 2). These results were certainly unanticipated,
because it is often assumed that the ability of fusion peptides
to promote fusion is related to their ability to disrupt the target
membrane outer leaﬂet, a process that would expose the
hydrocarbon interior to water and increase surface tension.
Determining fusion peptide structure on bilayers
The fusogenic conformation of fusion peptides remains
difﬁcult to deﬁne for several reasons. First, it is inherently
difﬁcult to determine the structure of membrane-associated
proteins, and especially of peptides, whose structure is
usually less well deﬁned than for a protein. Second, the
structure of a fusion peptide may depend on the nature of
the surface to which it is bound (18,55,56,66,67). Third, the
FIGURE 4 PATIR-FTIR amide I spectra of HA peptide (A) and gp41
peptide (B) on monolayers of POPC and DOPC/DOPE/SM/CH. Parallel-
polarized spectra are shown; perpendicularly polarized spectra had similar
shapes but slightly lower amplitudes.
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structure may also depend on the concentration of peptide or
other components (water, ions) at the surface (68–70). We
turned to a combination of ﬂuorescence, CD, and PATIR-
FTIR spectroscopies to gain insights into peptide structure.
Because infrared spectra are always weak relative to UV
spectra, it is necessary to use high P/L ratios (in our case,
nominally 1:10) to obtain interpretable data for clearly
deﬁned lipid monolayers interacting with peptide under full
hydration and deﬁned buffer conditions. Thus, our results
on peptide structure on membranes (CD) or monolayers
(PATIR-FTIR) are obtained at much higher surface con-
centrations (P/L ¼ 1/50 for CD and P/L ¼ 1/10 for FTIR)
than we have used to study peptide enhancement of PEG-
mediated fusion (P/L , 1:200) (23,24). We acknowledge
that the chemical nature of membrane interface and thus the
peptide structure may be different at the high P/L ratios at
which our CD and FTIR experiments are performed than
they are at the low ratios at which we have examined the effects
of peptides on fusion. This is an ambiguity with which nearly
any structural studies must live, and we acknowledge this in our
discussion. Although other FTIR studies have been performed
at much lower P/L ratios, the price of doing so is that these
studies are performed on lipid pastes in which solution con-
ditions are obscure. We accept the uncertainty associated with
a saturated surface concentration of peptide to examine peptide
structure under deﬁned solution conditions of hydration, pH,
ionic strength, and lipid structure (71).
Fusion peptide structure and fusogenicity
A recently published model of HA fusion peptide structure
(72) is based on NMR data obtained with detergent-
solubilized peptide and then electron spin resonance data
on membrane-bound peptide. In this model, an N-terminal
helix penetrates the bilayer at roughly 30 to the bilayer
surface. A C-terminal distorted helix lies roughly along the
bilayer surface at pH 7, allowing E-11 and N-12 to be in the
aqueous layer above the membrane. These helical regions are
linked by a region suggested by molecular dynamics
simulation to be ﬂexible (73) and containing G-13 as part
of a helix-breaking motif crucial to fusion peptide function
(27). This model was obtained with the fusion peptide acting
as a ‘‘guest’’ attached to a hydrophilic C-terminal ‘‘host’’
peptide, meaning that the C-terminal portion attached to the
host could be distorted from the structure formed by a host-
free peptide.
Our results indicate that Trp-14 is located fairly near the
interface with its indole side chain located ;9 A˚ from the
center of the bilayer (Table 2). Our PATIR-FTIR data sup-
port a largely helical structure. Our model places the N-term-
inal region at roughly a 30 angle to the surface so that
hydrophobic residues can locate to the midsection of the
monolayer. This is based on our ﬂuorescence results that the
hydrophobic packing in the membrane is increased due to
peptide binding and on the dichroic ratio of the helical amide
I band (Table 3). The arrangement of polar residues in the
C-terminus (i,i 1 4) suggests a distorted helix. To satisfy
the FTIR result, we assumed that the small helical region at
the C-terminus is also bent into the monolayer but at a small
angle of opposite sign to the penetration of the N-terminus.
The chain then returns to the surface to place Asp-19 in
the water layer above the bilayer. This model of the HA
fusion peptide is displayed in Fig. 5. The rough agree-
ment of our qualitative model for HA fusion peptide
with the NMR-based model (72) both suggests that the
host peptide used to obtain the NMR model did not signiﬁ-
cantly distort the HA fusion peptide structure and
lends credence to the reasoning behind the model adopted
here.
Unlike the HA peptide, the literature on the gp41 fusion
peptide suggests a mixture of secondary structures, with many
opinions on what determines the balance between struc-
tures: 1), surface concentration; 2), peptide oligomeric state;
3), membrane composition; and 4), membrane curvature.
TABLE 3 Recovered amide I components dichroic ratios for fusion peptides
gp41 (pD 7.5)* HA (pD 5.5)
POPC DOPC/DOPE/SM/CH POPC DOPC/DOPE/SM/CH
1614 cm1 RZ 1.4 6 0.9 0.9 6 0.2 – –
% 3.8 6 0.4 2.6 6 0.2 – –
1625 cm1 RZ 1.2 6 0.2 1.4 6 0.4 – 1.2 6 0.0
% 35.9 6 2.7 20.3 6 5.3 – 19.0 6 7.2
1632 cm1 RZ 2.0 6 0.4 1.7 6 0.1 – –
% 10.0 6 1.1 13.4 6 1.8 – –
1649 cm1 RZ 1.9 6 0.4 1.7 6 0.1 1.8 6 0.0 1.7 6 0.1
% 22.1 6 1.2 30.2 6 3.0 81.5 6 1.1 73.1 6 6.4
1677 cm1 RZ 2.1 6 1.2 1.7 6 0.2 1.8 6 0.0 1.9 6 0.0
% 13.5 6 1.3 25.3 6 4.7 6.2 6 0.2 7.9 6 3.2
1688 cm1 RZ 3.3 6 1.7 2.0 6 0.4 – –
% 6.9 6 0.0 4.4 6 0.7 – –
Minor components % 7.8 3.8 12.3 0.0
*Values listed are the average and range of two measurements. The b-sheet orientation, g, is calculated as described in methods. Percentages in each column
are amide I component areas and total 100%.
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Because of experimental limitations, we could not address sen-
sitivity to membrane curvature, although we have addressed
all the other issues mentioned.
Although there is agreement that the gp41 peptide is
primarily helical on acidic-lipid-containing membranes
(25,61,63), there is disagreement about the conformation
on a neutral membrane. Some report a-helix at P/L ratios
from 1:25 to 1:2000 (29), whereas most ﬁnd b-structure from
1:50 to 1:800 P/L (22,61,63), but there are no reports of a
variation in gp41 peptide structure with change in surface
concentration. Consistent with this, our results show that the
indole of Trp-8 in the gp41 mutant is located similarly with
respect to the bilayer center at low (P/L ¼ 1:400) and high
(P/L ¼ 1:50) surface concentrations (Table 2), although this
does not absolutely rule out a change in secondary structure
with surface concentration. At both 1:50 and 1:10 P/L ratios,
our results indicate a highly ordered structure with the
dominant secondary structure being antiparallel b-sheet.
This could be intra- or intermolecular b-sheet, as illustrated
in Fig. 5 (bottom and top right panels). Our observation that
a threshold surface concentration was needed to see the
effects of gp41 fusion peptide on membrane outer-leaﬂet
structure (Figs. 1 and 2) supports an intermolecular b-sheet
model at surface concentrations above ;1:60. Both possi-
bilities are presented in the lower panel of Fig. 5. Both
our models (intra- or intermolecular b-sheet) locate the
C-terminal charged residues (also with an i, i 1 4 repeat
consistent with a distorted amphipathic helical turn) at
the membrane interface and conﬁne the b-sheet to the
N-terminal region. Either model properly places the indole
relative to the membrane center and places hydrophobic
residues so that they reach into the interior of the bilayer,
where our ﬂuorescence data indicate that a portion of the
peptide must be located. The angle between the b-sheet axis
and the plane of the membrane is not implied by our PATIR-
FTIR data, but is consistent with these data and allows for
penetration of the hydrophobic residues into the regions of
the bilayer most affected by peptide binding to membranes.
Recent solid-state NMR studies provide direct spin-
coupling demonstration of b-sheet conformation involving
residues V2, F8, F11, and A15 at P/L of 1:20, although it was
not possible to distinguish between interpeptide or intra-
peptide (74). This same solid-state NMR study failed to
detect signiﬁcant structure in the C-terminal region, also
consistent with the model presented here.
Effect of membrane structure on peptide structure
Aside from the clear effect of basic membrane charge on the
gp41 peptide, we cannot derive from our results (Fig. 4 and
Table 3) a clear correlation between membrane structure
(fusogenic versus nonfusogenic) and either HA or gp41 fusion
peptide structure beyond acknowledging that the structures of
these fusion peptides are sensitive to the structure of the
membrane on which it is located, even for neutral membranes.
Analogous HA and gp41 fusion peptide
structures: a hypothesis for a structure/
fusion relationship
A recent two-dimensional NMR structure of gp41 fusion
peptide associated with sodium dodecyl sulfate micelles
shows the N-terminus as mainly micelle-embedded a-helix,
with a ﬂexible Gly-bend region (Leu-12-Gly-13-Ala-14-Ala-
15-Gly-16) joining this to a surface-located C-terminus (62).
This arrangement is quite analogous to that described for the
HA fusion peptide in dodecylphosphocholine micelles (72).
Basic polar residue pairs on the C-terminal side of the
ﬂexible link (Ser-17-Thr-18, Arg-22-Ser-23) of gp41 and the
acidic residues in the C-terminus of HA fusion peptide (Glu-
15, Asp-19) should be exposed to water. The (i,i 1 4 or 5)
repeat of these polar residues in both the gp41 and HA fusion
peptides is consistent with a distorted helix, with the polar
residues bending this so that they can occupy the membrane
interface. The regions of both the HA and gp41 fusion
peptides on the N-terminal side of the ﬂexible region are
hydrophobic. Because either a b-sheet or an a-helix will
satisfy the H-bonding requirements of these hydrophobic
N-terminal portions, either structure should be roughly
equivalent thermodynamically, except that there is not a clear
b-turn motif in the middle of either N-terminal sequence.
However, the turn potential for the gp41 peptide is greater
than for the HA peptide, which has a more clear helical
propensity. Thus, we suspect that either peptide, under appro-
priate surface conditions, could adopt either secondary structure.
In the models presented in Fig. 5, both fusion peptides have
roughly an inverted V-shape. Our hypothesis is that the angle
of the V determines the fusogenic conformation of either
FIGURE 5 Model of HA and gp41 peptides associated with lipid bilayers
based on depth of penetration and FTIR results. The detailed arguments that
led to these models are described in the Discussion. The models reﬂect our
hypothesis that, even though the two peptides adopt somewhat different
secondary structures, they interact with the bilayer with basically the same
structural organization, and promote fusion by the same mechanism. This
involves bilayer penetration by the hydrophobic N-terminus, thereby com-
pensating for hydrophobic mismatch and stabilizing fusion intermediates
leading to pore formation.
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fusion peptide and depends on the charge on the membrane
and on the charged C-terminal residues of the peptides. In this
hypothesis, both the Gly-bend region in the middle of the
peptides and the polar residues in the bend and C-terminus
(Ser-17, Thr-18 and Arg-22, Ser-23 pairs in gp41 and Glu-15
and Asp-19 in HA) are critical to the fusion conformation. The
polar residues dictate the orientation of the bend/C-terminus
with respect to the membrane surface and thus make the
structure of each peptide very sensitive to pH (HA peptide) and
to both the charge and packing of the membrane (gp41
peptide). We suggest that a fusion-promoting conformation of
either peptide is one that allows the C-terminal polar residues
the most freedom to leave the aqueous interface and penetrate
the membrane outer leaﬂet (i.e., adopt a more bent con-
formation). The low pH conformation a-helical form of the
HA fusion peptide is widely accepted as fusogenic (18,26,56),
and the NMR-based model for HA peptide shows that this
conformation allows greater penetration of the hydrophobic
N-terminus into the outer leaﬂet than does the neutral pH
conformation (72). The gp41 peptide promotes fusion on
neutral, well-packed, and highly curved membranes (24),
which we show here support a b-sheet in its N-terminus. Based
on the fact that the gp41 peptide has a different effect on
membrane packing than the a-helical HA peptide (Figs. 1 and
2), we conclude that the fusogenic conformation of the gp41
peptide under our experimental conditions is an intrapeptide
b-sheet that allows the N-terminal half of the peptide to pene-
trate the outer leaﬂet, although not as effectively as the a-helix
of the HA peptide. On membranes containing acidic lipids, the
basic C-terminal residues of gp41 would be more tightly an-
chored to the aqueous region just above the membrane surface,
leading to the a-helical N-terminus that would nonetheless be
inactive because of a less bent conformation.
This offers a possible biological rationalization for the gp41
peptide’s sensitivity to negative surface charge. The gp41
peptide has basic residues in the same C-terminal helical turn
positions where the HA peptide has acidic amino acids.
Apoptotic lymphocytes are rapidly coated with exposed
phosphatidylserine (75,76). If our hypothesis is correct, this
surface would favor an a-helical N-terminal region, whereas
the phosphatidylserine-depleted surface of a healthy lympho-
cyte would favor an N-terminal b-sheet that favored fusion
and infection.
The role of fusion peptides in promoting fusion:
intrinsic curvature versus HMM
The simian immunodeﬁciency virus destabilizes lamellar
and promotes hexagonal phase, leading to the speculation
that it has an effective negative intrinsic curvature (77). This
would be expected to frustrate packing, especially of the
highly positively curved outer leaﬂet of SUVs. Instead, both
peptides had the opposite effect: they decreased surface ten-
sion and ﬁlled hydrophobic space within the outer mono-
layer, especially for SUVs (Fig. 1 B) than for LUVs (Fig. 1
C). Consistent with this, neither peptide promoted water
penetration of the outer leaﬂet. Indeed, if these peptides can
relieve the curvature stress of SUVs, they should inhibit
fusion of these vesicles. Instead they promote PEG-mediated
fusion only of highly curved membranes, except in the
presence of hexadecane, when they inhibit fusion (23,24).
Hexadecane is a hydrocarbon shown to occupy space in the
hydrophobic mismatch (HMM) region of hexagonal phase
(78). Its presence in a membrane favors fusion by promoting
conversion of initial intermediate to a pore (79,80) and
competes with the fusion promoting effect of fusion peptides
(24). Thus, both the effects of fusion peptides on bilayer
structure (Figs. 1 and 2) and their effects on fusion (23,24)
support the hypothesis that the ability to ﬁll space within the
hydrophobic region of the outer monolayer promotes fusion.
It may be that fusion peptides also contribute an effective
negative intrinsic curvature (77), but this possibility must be
addressed by determining their effect on the hexagonal phase
transition in the presence of hexadecane to eliminate the
possibility that the peptides act by reducing unfavorable
HMM free energy. These experiments are underway, as are
experiments to determine the importance of the Gly-bends
and hydrophobic N-terminals, other key elements of our
hypothesis.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
We thank Dr. Ashetosh Tripathy of the University of North Carolina
Macromolecular Interactions Facility for help with CD measurements.
This work was supported by the United States Public Health Service
(GM32707 to B.R.L., GM54617 to P.H.A., and HL68186 to V.K.).
REFERENCES
1. White, J. M. 1990. Viral and cellular membrane fusion proteins. Annu.
Rev. Physiol. 52:675–697.
2. Leikina, E., I. Markovic, L. V. Chernomordik, and M. M. Kozlov.
2000. Delay of inﬂuenza hemagglutinin refolding into a fusion-
competent conformation by receptor binding: a hypothesis. Biophys. J.
79:1415–1427.
3. Markosyan, R. M., G. B. Melikyan, and F. S. Cohen. 1999. Tension of
membranes expressing the hemagglutinin of inﬂuenza virus inhibits
fusion. Biophys. J. 77:943–952.
4. Dimitrov, D. S., H. Golding, and R. Blumenthal. 1991. Initial stages of
HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new
assay based on redistribution of ﬂuorescent dyes. AIDS Res. Hum.
Retroviruses. 7:799–805.
5. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the
fusion domain of the human immunodeﬁciency virus type 1 envelope
glycoprotein gp41. Proc. Natl. Acad. Sci. USA. 87:4650–4654.
6. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennie, C. Shimasaki,
E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation
of a region of the human immunodeﬁciency virus type 1 gp120 gly-
coprotein critical for interaction with the CD4 receptor. Cell. 50:
975–985.
3192 Haque et al.
Biophysical Journal 89(5) 3183–3194
7. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A.
Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and
W. A. Paxton. 1996. HIV-1 entry into CD41 cells is mediated by the
chemokine receptor CC–CKR-5. Nature. 381:667–673.
8. Wilkinson, D. 1996. Cofactors provide the entry keys. HIV-1. Curr.
Biol. 6:1051–1053.
9. Broder, C. C., and D. S. Dimitrov. 1996. HIV and the 7-transmembrane
domain receptors. Pathobiology. 64:171–179.
10. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. Sattentau. 1993. The
HIV-Cell Fusion Reaction. J. Bentz, editor. CRC Press, Boca Raton,
FL, Ann Arbor, MI, London, UK, and Tokyo, Japan.
11. Durell, S. R., I. Martin, J. M. Ruysschaert, Y. Shai, and R. Blumenthal.
1997. What studies of fusion peptides tell us about viral envelope
glycoprotein-mediated membrane fusion (review). Mol. Membr. Biol.
14:97–112.
12. Hughson, F. M. 1995. Structural characterization of viral fusion
proteins. Curr. Biol. 5:265–274.
13. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. J. Sattentau. 1993.
Viral Fusion Mechanisms. CRC Press, Boca Raton, FL.
14. Gething, M. J., R. W. Doms, D. York, and J. White. 1986. Studies on
the mechanism of membrane fusion: site-speciﬁc mutagenesis of the
hemagglutinin of inﬂuenza virus. J. Cell Biol. 102:11–23.
15. Stegmann, T., J. M. Delﬁno, F. M. Richards, and A. Helenius. 1991.
The HA2 subunit of inﬂuenza hemagglutinin inserts into the target
membrane prior to fusion. J. Biol. Chem. 266:18404–18410.
16. Tsurudome, M., R. Gluck, R. Graf, R. Falchetto, U. Schaller, and J.
Brunner. 1992. Lipid interactions of the hemagglutinin HA2 NH2-
terminal segment during inﬂuenza virus-induced membrane fusion.
J. Biol. Chem. 267:20225–20232.
17. Wharton, S. A., S. R. Martin, R. W. Ruigrok, J. J. Skehel, and D. C.
Wiley. 1988. Membrane fusion by peptide analogues of inﬂuenza virus
haemagglutinin. J. Gen. Virol. 69:1847–1857.
18. Lear, J. D., and W. F. DeGrado. 1987. Membrane binding and
conformational properties of peptides representing the NH2 terminus of
inﬂuenza HA-2. J. Biol. Chem. 262:6500–6505.
19. Murata, M., Y. Sugahara, S. Takahashi, and S. Ohnishi. 1987. pH-
dependent membrane fusion activity of a synthetic twenty amino acid
peptide with the same sequence as that of the hydrophobic segment of
inﬂuenza virus hemagglutinin. J. Biochem. (Tokyo). 102:957–962.
20. Kliger, Y., A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y.
Shai. 1997. Fusion peptides derived from the HIV type 1 glycoprotein
41 associate within phospholipid membranes and inhibit cell-
cell fusion. Structure- function study. J. Biol. Chem. 272:13496–
13505.
21. Martin, I., F. Defrise-Quertain, E. Decroly, M. Vandenbranden, R.
Brasseur, and J. M. Ruysschaert. 1993. Orientation and structure of the
NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
Biochim. Biophys. Acta. 1145:124–133.
22. Pereira, F. B., F. M. Goni, A. Muga, and J. L. Nieva. 1997.
Permeabilization and fusion of uncharged lipid vesicles induced by the
HIV-1 fusion peptide adopting an extended conformation: dose and
sequence effects. Biophys. J. 73:1977–1986.
23. Haque, M. E., A. J. McCoy, J. Glenn, J. Lee, and B. R. Lentz. 2001.
Effects of hemagglutinin fusion peptide on poly(ethylene glycol)-
mediated fusion of phosphatidylcholine vesicles. Biochemistry. 40:
14243–14251.
24. Haque, M. E., and B. R. Lentz. 2002. Inﬂuence of gp41 fusion peptide
on the kinetics of poly(ethylene glycol)-mediated model membrane
fusion. Biochemistry. 41:10866–10876.
25. Nieva, J. L., S. Nir, A. Muga, F. M. Goni, and J. Wilschut. 1994.
Interaction of the HIV-1 fusion peptide with phospholipid vesicles:
different structural requirements for fusion and leakage. Biochemistry.
33:3201–3209.
26. Gray, C., S. A. Tatulian, S. A. Wharton, and L. K. Tamm. 1996. Effect
of the N-terminal glycine on the secondary structure, orientation, and
interaction of the inﬂuenza hemagglutinin fusion peptide with lipid
bilayers. Biophys. J. 70:2275–2286.
27. Matsumoto, T. 1999. Membrane destabilizing activity of inﬂuenza
virus hemagglutinin-based synthetic peptide: implications of critical
glycine residue in fusion peptide. Biophys. Chem. 79:153–162.
28. Pecheur, E. I., I. Martin, A. Bienvenue, J. M. Ruysschaert, and D.
Hoekstra. 2000. Protein-induced fusion can be modulated by target
membrane lipids through a structural switch at the level of the fusion
peptide. J. Biol. Chem. 275:3936–3942.
29. Curtain, C., F. Separovic, K. Nielsen, D. Craik, Y. Zhong, and A.
Kirkpatrick. 1999. The interactions of the N-terminal fusogenic peptide
of HIV-1 gp41 with neutral phospholipids. Eur. Biophys. J. 28:427–
436.
30. Epand, R. M., and R. F. Epand. 1994. Relationship between the
infectivity of inﬂuenza virus and the ability of its fusion peptide to
perturb bilayers. Biochem. Biophys. Res. Commun. 202:1420–1425.
31. Chen, P. S., Jr., T. Y. Toribara, and H. Warner. 1956. Microdeter-
mination of phosphorus. Anal. Chem. 28:1756–1758.
32. Schwenk, E., and N. T. Werthessen. 1952. Studies on the biosynthesis
of cholesterol. III. Puriﬁcation of C(14)-cholesterol from perfusions of
livers and other organs. Arch. Biochem. Biophys. 40:334–341.
33. Lentz, B. R., T. J. Carpenter, and D. R. Alford. 1987. Spontaneous
fusion of phosphatidylcholine small unilamellar vesicles in the ﬂuid
phase. Biochemistry. 26:5389–5397.
34. Hope, M. J., M. B. Bally, G. Webb, and P. R. Cullis. 1985. Produc-
tion of large unilamellar vesicles by a rapid extrusion procedure:
characterization of size distribution, trapped volume and ability to
maintain a membrane potential. Biochim. Biophys. Acta. 812:55–65.
35. Lentz, B. R., G. F. McIntyre, D. J. Parks, J. C. Yates, and D.
Massenburg. 1992. Bilayer curvature and certain amphipaths promote
poly(ethylene glycol)-induced fusion of dipalmitoylphosphatidylcho-
line unilamellar vesicles. Biochemistry. 31:2643–2653.
36. Lee, J., and B. R. Lentz. 1997. Outer leaﬂet-packing defects promote
poly(ethylene glycol)-mediated fusion of large unilamellar vesicles.
Biochemistry. 36:421–431.
37. Chattopadhyay, A., and E. London. 1987. Parallax method for direct
measurement of membrane penetration depth utilizing ﬂuores-
cence quenching by spin-labeled phospholipids. Biochemistry. 26:39–
45.
38. Lewis, B. A., and D. M. Engelman. 1983. Lipid bilayer thickness
varies linearly with acyl chain length in ﬂuid phosphatidylcholine
vesicles. J. Mol. Biol. 166:211–217.
39. McIntosh, T. J., and P. W. Holloway. 1987. Determination of the depth
of bromine atoms in bilayers formed from bromolipid probes.
Biochemistry. 26:1783–1788.
40. Sreerama, N., and R. W. Woody. 2000. Estimation of protein
secondary structure from circular dichroism spectra: comparison of
CONTIN, SELCON, and CDSSTR methods with an expanded
reference set. Anal. Biochem. 287:252–260.
41. Silvestro, L., and P. H. Axelsen. 1998. Infrared spectroscopy of
supported lipid monolayer, bilayer, and multibilayer membranes.
Chem. Phys. Lipids. 96:69–80.
42. Axelsen, P. H., W. D. Braddock, H. L. Brockman, C. M. Jones, R. A.
Dluhy, B. K. Kaufman, and F. J. Puga II. 1995. Use of internal
reﬂectance infrared spectroscopy for the in-situ study of supported lipid
monolayers. Appl. Spectrosc. 49:526–531.
43. Silvestro, L., and P. H. Axelsen. 1999. Fourier transform infrared
linked analysis of conformational changes in annexin V upon mem-
brane binding. Biochemistry. 38:113–121.
44. Axelsen, P. H., and M. J. Citra. 1996. Orientational order determination
by internal reﬂection infrared spectroscopy. Prog. Biophys. Mol. Biol.
66:227–253.
45. Silvestro, L., and P. H. Axelsen. 2000. Membrane-induced folding of
cecropin A. Biophys. J. 79:1465–1477.
46. Slater, S. J., M. B. Kelly, F. J. Taddeo, C. Ho, E. Rubin, and C. D.
Stubbs. 1994. The modulation of protein kinase C activity by mem-
brane lipid bilayer structure. J. Biol. Chem. 269:4866–4871.
Role of Viral Fusion Peptide Structure in Promoting Fusion 3193
Biophysical Journal 89(5) 3183–3194
47. Rafalski, M., A. Ortiz, A. Rockwell, L. C. van Ginkel, J. D. Lear, W. F.
DeGrado, and J. Wilschut. 1991. Membrane fusion activity of the
inﬂuenza virus hemagglutinin: interaction of HA2 N-terminal peptides
with phospholipid vesicles. Biochemistry. 30:10211–10220.
48. Pecheur, E. I., J. Sainte-Marie, A. Bienvenu¨e, and D. Hoekstra. 1999.
Peptides and membrane fusion: towards an understanding of the
molecular mechanism of protein-induced fusion. J. Membr. Biol.
167:1–17.
49. Koppaka, V., and B. R. Lentz. 1996. Binding of bovine factor Va to
phosphatidylcholine membranes. Biophys. J. 70:2930–2937.
50. Lentz, B. R. 1993. Use of ﬂuorescent probes to monitor molecular
order and motions within liposome bilayers. Chem. Phys. Lipids. 64:
99–116.
51. Stubbs, C. D., C. Ho, and S. J. Slater. 1995. Fluorescence techniques
for probing water penetration into lipid bilayers. J. Fluo. 5.
52. Clague, M. J., J. R. Knutson, R. Blumenthal, and A. Herrmann. 1991.
Interaction of inﬂuenza hemagglutinin amino-terminal peptide with
phospholipid vesicles: a ﬂuorescence study. Biochemistry. 30:5491–
5497.
53. Zhelev, D. V., N. Stoicheva, P. Scherrer, and D. Needham. 2001.
Interaction of synthetic HA2 inﬂuenza fusion peptide analog with
model membranes. Biophys. J. 81:285–304.
54. Luneberg, J., I. Martin, F. Nussler, J. M. Ruysschaert, and A.
Herrmann. 1995. Structure and topology of the inﬂuenza virus fusion
peptide in lipid bilayers. J. Biol. Chem. 270:27606–27614.
55. Burger, K. N., S. A. Wharton, R. A. Demel, and A. J. Verkleij. 1991.
The interaction of synthetic analogs of the N-terminal fusion sequence
of inﬂuenza virus with a lipid monolayer. Comparison of fusion-
active and fusion-defective analogs. Biochim. Biophys. Acta. 1065:
121–129.
56. Takahashi, S. 1990. Conformation of membrane fusion-active 20-
residue peptides with or without lipid bilayers. Implication of alpha-
helix formation for membrane fusion. Biochemistry. 29:6257–6264.
57. Murata, M., S. Takahashi, S. Kagiwada, A. Suzuki, and S. Ohnishi.
1992. pH-dependent membrane fusion and vesiculation of phospho-
lipid large unilamellar vesicles induced by amphiphilic anionic and
cationic peptides. Biochemistry. 31:1986–1992.
58. Ishiguro, R., N. Kimura, and S. Takahashi. 1993. Orientation of fusion-
active synthetic peptides in phospholipid bilayers: determination by
Fourier transform infrared spectroscopy. Biochemistry. 32:9792–9797.
59. Ishiguro, R., M. Matsumoto, and S. Takahashi. 1996. Interaction of
fusogenic synthetic peptide with phospholipid bilayers: orientation of
the peptide alpha-helix and binding isotherm. Biochemistry. 35:4976–
4983.
60. Luneberg, J., I. Martin, F. Nussler, J. M. Ruysschaert, and A.
Herrmann. 1995. Structure and topology of the inﬂuenza virus fusion
peptide in lipid bilayers. J. Biol. Chem. 270:27606–27614.
61. Rafalski, M., J. D. Lear, and W. F. DeGrado. 1990. Phospholipid
interactions of synthetic peptides representing the N- terminus of HIV
gp41. Biochemistry. 29:7917–7922.
62. Chang, D. K., S. F. Cheng, and W. J. Chien. 1997. The amino-terminal
fusion domain peptide of human immunodeﬁciency virus type 1 Gp41
inserts into the sodium dodecyl sulfate micelle primarily as helix with
a conserved glycine at the micelle-water interface. J. Virol. 71:6593–
6602.
63. Bodner, M. L., C. M. Gabrys, P. D. Parkanzky, J. Yang, C. A. Duskin,
and D. P. Weliky. 2004. Temperature dependence and resonance
assignment of 13C NMR spectra of selectively and uniformly labeled
fusion peptides associated with membranes. Magn. Reson. Chem.
42:187–194.
64. Krimm, S., and J. Bandekar. 1986. Vibrational spectroscopy and
conformation of peptides, polypeptides, and proteins. Adv. Protein
Chem. 38:181–364.
65. Wimley, W. C., K. Hristova, A. S. Ladokhin, L. Silvestro, P. H.
Axelsen, and S. H. White. 1998. Folding of beta-sheet membrane
proteins: a hydrophobic hexapeptide model. J. Mol. Biol. 277:1091–
1110.
66. Slepushkin, V. A., S. M. Andreev, M. V. Sidorova, G. B. Melikyan,
V. B. Grigoriev, V. M. Chumakov, A. E. Grinfeldt, R. A. Manukyan,
and E. V. Karamov. 1992. Investigation of human immunodeﬁciency
virus fusion peptides. Analysis of interrelations between their structure
and function. AIDS Res. Hum. Retroviruses. 8:9–18.
67. Terletskaya, Y. T., I. O. Trikash, E. S. Serdyuk, and S. M. Andreev.
1995. Fusion of negatively charged liposomes induced by peptides of
the N-terminal fragment of HIV-1 transmembrane protein. Biochem-
istry (Mosc.). 60:1309–1314.
68. Gordon, L. M., C. C. Curtain, Y. C. Zhong, A. Kirkpatrick, P. W.
Mobley, and A. J. Waring. 1992. The amino-terminal peptide of HIV-1
glycoprotein 41 interacts with human erythrocyte membranes: peptide
conformation, orientation and aggregation. Biochim. Biophys. Acta.
1139:257–274.
69. Martin, I., H. Schaal, A. Scheid, and J. M. Ruysschaert. 1996. Lipid
membrane fusion induced by the human immunodeﬁciency virus type
1 gp41 N-terminal extremity is determined by its orientation in the lipid
bilayer. J. Virol. 70:298–304.
70. Yang, J., C. M. Gabrys, and D. P. Weliky. 2001. Solid-state nuclear
magnetic resonance evidence for an extended beta strand conformation
of the membrane-bound HIV-1 fusion peptide. Biochemistry. 40:8126–
8137.
71. Koppaka, V., L. Silvestro, J. A. Engler, C. G. Brouillette, and P. H.
Axelsen. 1999. The structure of human lipoprotein A-I. Evidence for
the ‘‘belt’’ model. J. Biol. Chem. 274:14541–14544.
72. Han, X., J. H. Bushweller, D. S. Caﬁso, and L. K. Tamm. 2001.
Membrane structure and fusion-triggering conformational change of
the fusion domain from inﬂuenza hemagglutinin. Nat. Struct. Biol.
8:715–720.
73. Vaccaro, L., K. J. Cross, J. Kleinjung, S. K. Straus, D. J. Thomas, S. A.
Wharton, J. J. Skehel, and F. Fraternali. 2005. Plasticity of inﬂuenza
haemagglutinin fusion peptides and their interaction with lipid bilayers.
Biophys. J. 88:25–36.
74. Yang, J., and D. P. Weliky. 2003. Solid-state nuclear magnetic
resonance evidence for parallel and antiparallel strand arrangements
in the membrane-associated HIV-1 fusion peptide. Biochemistry.
42:11879–11890.
75. Clodi, K., K. O. Kliche, S. Zhao, D. Weidner, T. Schenk, U. Consoli,
S. Jiang, V. Snell, and M. Andreeff. 2000. Cell-surface exposure of
phosphatidylserine correlates with the stage of ﬂudarabine-induced
apoptosis in chronic lymphocytic leukemia and expression of
apoptosis-regulating genes. Cytometry. 40:19–25.
76. Mourdjeva, M., D. Kyurkchiev, A. Mandinova, I. Altankova, I.
Kehayov, S. Kyurkchiev, K. Clodi, K. O. Kliche, S. Zhao, D. Weidner,
T. Schenk, U. Consoli, et al. 2005. Dynamics of membrane trans-
location of phosphatidylserine during apoptosis detected by a mono-
clonal antibody. Cell-surface exposure of phosphatidylserine correlates
with the stage of ﬂudarabine-induced apoptosis in chronic lymphocytic
leukemia and expression of apoptosis-regulating genes. Apoptosis.
10:209–217.
77. Colotto, A., I. Martin, J. M. Ruysschaert, A. Sen, S. W. Hui, and R. M.
Epand. 1996. Structural study of the interaction between the SIV fusion
peptide and model membranes. Biochemistry. 35:980–989.
78. Chen, Z., and R. P. Rand. 1998. Comparative study of the effects of
several n-alkanes on phospholipid hexagonal phases. Biophys. J. 74:
944–952.
79. Malinin, V. S., P. Frederik, and B. R. Lentz. 2002. Osmotic and
curvature stress affect PEG-induced fusion of lipid vesicles but not
mixing of their lipids. Biophys. J. 82:2090–2100.
80. Malinin, V., and B. R. Lentz. 2004. Energetics of vesicle fusion
intermediates: comparison of calculations with observed effects of
osmotic and curvature stresses. Biophys. J. 86:2951–2964.
3194 Haque et al.
Biophysical Journal 89(5) 3183–3194
